Burt Nabors

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia et al. · The Lancet Oncology · 2014 · 1K citations

Medicine, Oncology, Pharmacotherapy +14

Human cytomegalovirus infection and expression in human malignant glioma.

Charles Cobbs, Lualhati Harkins, Minu Samanta et al. · PubMed · 2002 · 719 citations

Medicine, Cancer Biology, Oncology +10

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 719 citations · Full text

Medicine, Neurology, Oncology +8

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

Tracy T. Batchelor, Paul Mulholland, Bart Neyns et al. · Journal of Clinical Oncology · 2013 · 598 citations · Full text

Medicine, Oncology, Pharmacology +17

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia et al. · Journal of the National Comprehensive Cancer Network · 2020 · 564 citations · Full text

Medicine, Oncology, Radiation Oncology +17